secwatch / observer
8-K filed July 11, 2023, 7:59 PM ET CIK 0001410939
M&A confidence high sentiment neutral materiality 1.00

IVERIC bio, Inc.: M&A transaction — Astellas completes $5.9B acquisition of IVERIC bio; shareholders receive $40.00 per share

IVERIC bio, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark S. Blumenkranz

Director
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
Departed

Calvin W. Roberts

Director
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
Departed

Axel Bolte

Director
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
Departed

Jane P. Henderson

Director
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
Departed

Pravin U. Dugel

Director
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
Appointed

Mark Reisenauer

Director
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
at the Effective Time, the sole director of Merger Sub became the sole director of IVERIC.
Departed

Christine A. Miller

Director
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
Departed

Glenn P. Sblendorio

Director
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
Appointed

Mark Reisenauer

Officer
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
at the Effective Time, the sole officer of Merger Sub became the sole officer of IVERIC.
Departed

Adrienne L. Graves

Director
IVERIC bio, Inc.
Effective
2023-07-11
Filed
July 11, 2023, 7:59 PM ET
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Mark S. Blumenkranz resigned as Director at IVERIC bio, Inc..

Action
resigned
Role
Director
Exact text from the filing
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Calvin W. Roberts resigned as Director at IVERIC bio, Inc..

Action
resigned
Role
Director
Exact text from the filing
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Axel Bolte resigned as Director at IVERIC bio, Inc..

Action
resigned
Role
Director
Exact text from the filing
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Jane P. Henderson resigned as Director at IVERIC bio, Inc..

Action
resigned
Role
Director
Exact text from the filing
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Pravin U. Dugel resigned as Director at IVERIC bio, Inc..

Action
resigned
Role
Director
Exact text from the filing
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Mark Reisenauer was appointed as Director at IVERIC bio, Inc..

Action
became
Role
Director
Exact text from the filing
at the Effective Time, the sole director of Merger Sub became the sole director of IVERIC.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Christine A. Miller resigned as Director at IVERIC bio, Inc..

Action
resigned
Role
Director
Exact text from the filing
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Glenn P. Sblendorio resigned as Director at IVERIC bio, Inc..

Action
resigned
Role
Director
Exact text from the filing
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Mark Reisenauer was appointed as Officer at IVERIC bio, Inc..

Action
became
Role
Officer
Exact text from the filing
at the Effective Time, the sole officer of Merger Sub became the sole officer of IVERIC.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Adrienne L. Graves resigned as Director at IVERIC bio, Inc..

Action
resigned
Role
Director
Exact text from the filing
each of the directors of IVERIC (Glenn P. Sblendorio, Pravin U. Dugel, Mark S. Blumenkranz, Axel Bolte, Adrienne L. Graves, Jane P. Henderson, Christine A. Miller and Calvin W. Roberts) resigned as a member of the board of directors of IVERIC as of the Effective Time.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

IVERIC bio, Inc.: Amended and restated the certificate of incorporation to conform to the form set forth in the merger agreement.

Change
charter amendment
Exact text from the filing
At the Effective Time, the Restated Certificate of Incorporation of IVERIC, as in effect immediately prior to the Effective Time, was amended and restated to be in the form of the amended and restated certificate of incorporation set forth on Annex I to the Merger Agreement
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

IVERIC bio, Inc.: Amended and restated the bylaws to conform to the bylaws of Merger Sub.

Change
bylaw amendment
Exact text from the filing
In addition, at the Effective Time, IVERIC’s bylaws, as in effect immediately prior to the Effective Time, were amended and restated to conform to the bylaws of Merger Sub as of immediately prior to the Effective Time, except that references to the name of Merger Sub were replaced by the name of IVERIC
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

IVERIC bio, Inc. underwent a change of control involving Astellas US Holding, Inc. for $40.00 per Share in cash (closed 2023-07-11).

Action
change of control
Counterparty
Astellas US Holding, Inc.
Consideration
$40.00 per Share in cash
Closing
2023-07-11
Exact text from the filing
of common stock, par value $0.001 per share, of IVERIC (a “ Share ”) outstanding immediately prior to the effective time of the Merger was converted into the right to receive $40.00 per Share in cash, without interest (the “ Per Share Merger Consideration ”) less any applicable withholding taxes (except for any Shares owned by (1) IVERIC, (2) Parent or Merger
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IVERIC bio, Inc. terminated IVERIC Credit Agreement with Hercules Capital, Inc., as administrative agent and collateral agent (effective 2023-07-11).

Action
termination
Agreement
credit facility
Counterparty
Hercules Capital, Inc., as administrative agent and collateral agent
Effective
2023-07-11
Exact text from the filing
On July 11, 2023, in connection with the Merger, IVERIC repaid in full all outstanding indebtedness and all other amounts due and payable and terminated all commitments under that certain Loan and Security Agreement, dated as of July 26, 2022 (as amended, restated, amended and restated, supplemented and otherwise modified from time to time prior to the Closing Date, the “ IVERIC Credit Agreement ”), by and among IVERIC and each of its subsidiaries party thereto, as borrowers, the lenders party thereto and Hercules Capital, Inc., as administrative agent and collateral agent.
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001104659-23-079843
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.